In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Codexis nets $72.5mm via IPO

Executive Summary

Codexis Inc. (biocatalytic processes) has netted $72.5mm through its initial public offering of 6mm common shares at $13 each, the low end of its $13-15 range. The company originally filed for the IPO in April 2008, withdrew the registration statement five months later, then revived the offering 15 months after that.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
    • Synthesis Technologies, Production Processes
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies